208 related articles for article (PubMed ID: 23845026)
1. Genetically humanized mouse models of drug metabolizing enzymes and transporters and their applications.
Scheer N; Wolf CR
Xenobiotica; 2014 Jan; 44(2):96-108. PubMed ID: 23845026
[TBL] [Abstract][Full Text] [Related]
2. Drug-metabolizing enzyme, transporter, and nuclear receptor genetically modified mouse models.
Jiang XL; Gonzalez FJ; Yu AM
Drug Metab Rev; 2011 Feb; 43(1):27-40. PubMed ID: 20854191
[TBL] [Abstract][Full Text] [Related]
3. Humanized transgenic mouse models for drug metabolism and pharmacokinetic research.
Shen HW; Jiang XL; Gonzalez FJ; Yu AM
Curr Drug Metab; 2011 Dec; 12(10):997-1006. PubMed ID: 22023319
[TBL] [Abstract][Full Text] [Related]
4. Drug-drug Interactions of Angiotensin Converting Enzyme Inhibitors Mediated by Metabolizing Enzymes and Transporters.
Sun P; Liu K
Curr Drug Metab; 2018; 19(13):1119-1129. PubMed ID: 30062958
[TBL] [Abstract][Full Text] [Related]
5. The effect of Nrf2 knockout on the constitutive expression of drug metabolizing enzymes and transporters in C57Bl/6 mice livers.
Anwar-Mohamed A; Degenhardt OS; El Gendy MA; Seubert JM; Kleeberger SR; El-Kadi AO
Toxicol In Vitro; 2011 Jun; 25(4):785-95. PubMed ID: 21281708
[TBL] [Abstract][Full Text] [Related]
6. Differences in Toxicological and Pharmacological Responses Mediated by Polymorphic Cytochromes P450 and Related Drug-Metabolizing Enzymes.
Yamazaki H
Chem Res Toxicol; 2017 Jan; 30(1):53-60. PubMed ID: 27750412
[TBL] [Abstract][Full Text] [Related]
7. Chimeric mice with humanized liver.
Katoh M; Tateno C; Yoshizato K; Yokoi T
Toxicology; 2008 Apr; 246(1):9-17. PubMed ID: 18248870
[TBL] [Abstract][Full Text] [Related]
8. Regulation of brain drug metabolizing enzymes and transporters by nuclear receptors.
Xu D; Huang S; Wang H; Xie W
Drug Metab Rev; 2018 Nov; 50(4):407-414. PubMed ID: 30501435
[TBL] [Abstract][Full Text] [Related]
9. Expression and Regulation of Drug Transporters and Metabolizing Enzymes in the Human Gastrointestinal Tract.
Drozdzik M; Oswald S
Curr Med Chem; 2016; 23(39):4468-4489. PubMed ID: 27781942
[TBL] [Abstract][Full Text] [Related]
10. In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor.
Reese MJ; Savina PM; Generaux GT; Tracey H; Humphreys JE; Kanaoka E; Webster LO; Harmon KA; Clarke JD; Polli JW
Drug Metab Dispos; 2013 Feb; 41(2):353-61. PubMed ID: 23132334
[TBL] [Abstract][Full Text] [Related]
11. Role of constitutive androstane receptor in Toll-like receptor-mediated regulation of gene expression of hepatic drug-metabolizing enzymes and transporters.
Shah P; Guo T; Moore DD; Ghose R
Drug Metab Dispos; 2014 Jan; 42(1):172-81. PubMed ID: 24194512
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of mRNA expression of human drug-metabolizing enzymes and transporters in chimeric mouse with humanized liver.
Nishimura M; Yoshitsugu H; Yokoi T; Tateno C; Kataoka M; Horie T; Yoshizato K; Naito S
Xenobiotica; 2005 Sep; 35(9):877-90. PubMed ID: 16308282
[TBL] [Abstract][Full Text] [Related]
13. P450-Humanized and Human Liver Chimeric Mouse Models for Studying Xenobiotic Metabolism and Toxicity.
Bissig KD; Han W; Barzi M; Kovalchuk N; Ding L; Fan X; Pankowicz FP; Zhang QY; Ding X
Drug Metab Dispos; 2018 Nov; 46(11):1734-1744. PubMed ID: 30093418
[TBL] [Abstract][Full Text] [Related]
14. Novel pre-clinical methodologies for pharmacokinetic drug-drug interaction studies: spotlight on "humanized" animal models.
Jaiswal S; Sharma A; Shukla M; Vaghasiya K; Rangaraj N; Lal J
Drug Metab Rev; 2014 Nov; 46(4):475-93. PubMed ID: 25270219
[TBL] [Abstract][Full Text] [Related]
15. Changes of Transporters and Drug-metabolizing Enzymes in Nephrotic Syndrome.
Dong Y; Gong L; Lu X; Ye M; Lin Y; Xie S; Zhang J; Zhou F; Tang L; Zou W; Liu M
Curr Drug Metab; 2020; 21(5):368-378. PubMed ID: 32394830
[TBL] [Abstract][Full Text] [Related]
16. Effect of graded Nrf2 activation on phase-I and -II drug metabolizing enzymes and transporters in mouse liver.
Wu KC; Cui JY; Klaassen CD
PLoS One; 2012; 7(7):e39006. PubMed ID: 22808024
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of Mucosal Membrane Transporters and Drug-Metabolizing Enzymes in Ulcerative Colitis.
Erdmann P; Bruckmueller H; Martin P; Busch D; Haenisch S; Müller J; Wiechowska-Kozlowska A; Partecke LI; Heidecke CD; Cascorbi I; Drozdzik M; Oswald S
J Pharm Sci; 2019 Feb; 108(2):1035-1046. PubMed ID: 30267783
[TBL] [Abstract][Full Text] [Related]
18. Emerging in vitro tools to evaluate cytochrome P450 and transporter-mediated drug-drug interactions.
Lu C; Liao M; Cohen L; Xia CQ
Curr Drug Discov Technol; 2010 Sep; 7(3):199-222. PubMed ID: 20843292
[TBL] [Abstract][Full Text] [Related]
19. Alterations of drug-metabolizing enzymes and transporters under diabetic conditions: what is the potential clinical significance?
Chen F; Li DY; Zhang B; Sun JY; Sun F; Ji X; Qiu JC; Parker RB; Laizure SC; Xu J
Drug Metab Rev; 2018 Aug; 50(3):369-397. PubMed ID: 30221555
[TBL] [Abstract][Full Text] [Related]
20. Dietary Isoflavones as Modulators of Drug Metabolizing Enzymes and Transporters: Effect on Prescription Medicines.
Taneja I; Raju KS; Wahajuddin M
Crit Rev Food Sci Nutr; 2016 Jul; 56 Suppl 1():S95-S109. PubMed ID: 26561312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
